cp wire

CP Wire Articles

Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
  • 10 new cohorts added
  • 8 cohorts added in January of 2018
  • Trial could include up to 640 patients total


Exelixis, Inc. (Nasdaq:EXEL) announced on 6/1/2018 an... read more

Fri, 06/1/18 - 09:37 am
Siolta Therapeutics and CoreBiome – a Look at Two Different Ways Biotech is Developing Microbiome Related Products

Siolta Therapeutics is focused on treating inflammatory and allergic diseases via live biotherapeutics (LBTs) to improve the functioning of the gut microbiome. They are working to develop... read more

Thu, 05/31/18 - 09:59 am
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
  • Shares up over 47% in premarket trading
  • vTv will receive upfront payment and is eligible for future milestones and royalties
  • Partner intends to develop COPD treatment... read more
Thu, 05/31/18 - 09:28 am
CAMP4 Therapeutics Receives $30 Million Series A to Continue Developing Unique Discovery Platform

CAMP4 Therapeutics  is on a mission to modernize the way the pharma industry discovers new treatments. Operating at the intersection of biology and computation, CAMP4 is building on seminal... read more

Thu, 05/31/18 - 09:28 am
T2 Biosystems Announces Proposed Public Offering of Common Stock

T2 Biosystems, Inc. (Nasdaq:TTOO) announced on 5/30/18 that it is commencing an underwritten registered public offering of 5,650,000 shares of its common stock. T2 Biosystems also intends to grant... read more

Wed, 05/30/18 - 11:30 am

Pages